SEI Investments’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,106
Closed -$863K 2732
2023
Q4
$863K Sell
29,106
-164,596
-85% -$3.28M ﹤0.01% 1923
2023
Q3
$3.07M Buy
193,702
+1,263
+0.7% +$21K 0.01% 1389
2023
Q2
$3.63M Buy
192,439
+147,318
+326% +$1.74M 0.01% 1354
2023
Q1
$173K Buy
+45,121
New +$192K ﹤0.01% 2506
2019
Q2
Sell
-540
Closed -$1K 2839
2019
Q1
$1K Buy
+540
New +$2.34K ﹤0.01% 2884
2018
Q3
Sell
-1,200
Closed -$12K 3550
2018
Q2
$12K Sell
1,200
-87
-7% -$917 ﹤0.01% 2956
2018
Q1
$14K Sell
1,287
-54
-4% -$533 ﹤0.01% 2775
2017
Q4
$9K Buy
1,341
+46
+4% +$284 ﹤0.01% 2833
2017
Q3
$10K Buy
1,295
+95
+8% +$631 ﹤0.01% 2697
2017
Q2
$9K Buy
1,200
+700
+140% +$3.2K ﹤0.01% 2617
2017
Q1
$2K Hold
500
﹤0.01% 2741
2016
Q4
$1K Hold
500
﹤0.01% 2849
2016
Q3
$1K Buy
500
+471
+1,624% +$1.37K ﹤0.01% 2770
2016
Q2
$0 Buy
+29
New +$182 ﹤0.01% 2787
2015
Q4
Sell
-41,052
Closed -$394K 2723
2015
Q3
$394K Buy
+41,052
New +$600K ﹤0.01% 1373

Other funds holding IMGN

SEI Investments's IMGN Position: Q1 2024 in Review

SEI Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 29,106 shares — an estimated $863K sold.

SEI Investments first reported a position in IMGN in Q3 2015 and held it in 15 quarters. The position peaked at $3.63M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • SEI Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • SEI Investments sold 29,106 Immunogen Inc shares in Q1 2024, an estimated $863K.
  • SEI Investments first reported a position in Immunogen Inc in Q3 2015 and held it in 15 quarters.
  • SEI Investments's Immunogen Inc position peaked at $3.63M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on SEI Investments's 13F filing for Q1 2024, filed 7 May 2024.